Clinical Trials Directory

Trials / Completed

CompletedNCT02556255

Safety and Effectiveness Study of Eximo's B-Laser™ Atherectomy Device for PAD Treatment

Safety and Effectiveness Evaluation of Eximo's B-Laser™ Atherectomy Device, in Subjects Affected With PAD

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
57 (actual)
Sponsor
Eximo Medical Ltd. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to assess the safety and efficacy of the use of the Eximo's B-Laser™ catheter in subjects affected with Peripheral Artery Disease (PAD) in lower extremity arteries.

Detailed description

This is a prospective, single-arm, multi-center, international, open-label, non-randomized clinical study. All enrolled subjects will undergo atherectomy procedure, during which the B-Laser™ catheter will be used to perform atherectomy in target lesion, followed by any other adjunctive therapy (balloon and/or stent etc.). The procedure will be done according to standard hospital procedure for atherectomy. The steps of the operation before and after the operating of the B-Laser™ device are routinely used practice and will be done according to local practice at each hospital. For the post-atherectomy stage, as an adjunctive therapy in the procedure, any approved device may be used (balloon and/or stent etc.). Subjects will then be followed for 12 months after the procedure.

Conditions

Interventions

TypeNameDescription
DEVICEB-Laser™ Atherectomy CatheterLaser atherectomy catheter based on 355 nm

Timeline

Start date
2015-10-01
Primary completion
2017-08-01
Completion
2020-11-20
First posted
2015-09-22
Last updated
2021-03-03
Results posted
2019-02-21

Locations

2 sites across 1 country: Poland

Source: ClinicalTrials.gov record NCT02556255. Inclusion in this directory is not an endorsement.